SOVA PHARMACEUTICALS INC has a total of 33 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are AMPLA PHARMACEUTICALS INC, SALVAT LAB SA and DAI DONGCHENG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | China | 3 | |
#6 | Argentina | 2 | |
#7 | Canada | 2 | |
#8 | Hong Kong | 2 | |
#9 | India | 2 | |
#10 | Taiwan | 2 | |
#11 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Chapman Justin | 28 |
#2 | Sydserff Simon G | 28 |
#3 | Stein Gregory | 26 |
#4 | Rao Srinivas G | 25 |
#5 | Duron Sergio G | 18 |
#6 | Wade Warren | 11 |
#7 | Durón Sergio G | 6 |
#8 | Justin Chapman | 4 |
#9 | Gregory Stein | 4 |
#10 | Simon G Sydserff | 4 |
Publication | Filing date | Title |
---|---|---|
WO2015112902A2 | CYSTATHIONINE-(gamma)-LYASE (CSE) INHIBITORS FOR TREATING PAIN | |
US2015272934A1 | Use of cse inhibitors for the treatment of cutaneous injuries or conditions and sleep-related breathing disorders | |
CN109748881A | Cystathionie-γ-lyase (CSE) inhibitor | |
US2015266837A1 | Cystathionine-γ-lyase (CSE) inhibitors | |
WO2013028909A1 | Combination therapy for the treatment of sleep-related breathing disorders |